News Industry News Abbott to Present Data on Novel Vascular Technologies and XIENCE V® at ACC 2011 March 28, 2011
News Industry News Abbott Receives CE Mark Approval for World's First Drug Eluting Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease January 09, 2011